Fluciclovine is a potential imaging biomarker of glutamine utilisation in breast cancer
Main Authors: | Teoh, EJ, Bridges, EM, Morotti, M, Zois, CE, Lord, SR, Gleeson, FV, Harris, AL |
---|---|
Formato: | Conference item |
Idioma: | English |
Publicado: |
Springer
2017
|
Títulos similares
-
Fluciclovine (F-18) is a marker for high-affinity glutamine transporter ASCT2-mediated amino acid transport in breast cancer
por: Teoh, E, et al.
Publicado: (2017) -
Characterising ¹⁸F-fluciclovine uptake in breast cancer through the use of dynamic PET/CT imaging
por: Scott, NP, et al.
Publicado: (2021) -
Cancer imaging with fluciclovine (18F)
por: Teoh, E
Publicado: (2018) -
Increased expression of glutamine transporter SNAT2/SLC38A2 promotes glutamine dependence and oxidative stress resistance, and is associated with worse prognosis in triple-negative breast cancer
por: Morotti, M, et al.
Publicado: (2020) -
Glutamine deprivation alters the origin and function of cancer cell exosomes
por: Fan, S, et al.
Publicado: (2020)